The Effect of Progressive Relaxation Exercises on Dyspnea and Anxiety Levels in Individuals With COPD: A Randomized Controlled Trial. Issue 1 (January 2023)

• Record Type: Journal Article
• Authors: Kılıç, Züleyha; Karadağ, Songül; Tutar, Nuri
• Is Part Of: Holistic nursing practice. Volume 37:Issue 1(2023)
• Page Start: E14
• Page End: E23
• Publication Date: 2023-01
• Subjects: anxiety -- COPD -- dyspnea -- nursing -- progressive relaxation exercise; Holistic nursing -- Periodicals; Holistic medicine -- Periodicals; Nursing -- Philosophy -- Periodicals; 615.5
• DOI: 10.1097/HNP.0000000000000563
• Languages: English
• ISSNs: 0887-9311

Abstract

Abstract : Dyspnea is a common symptom and anxiety is a common comorbidity of chronic obstructive pulmonary disease (COPD). They affect individuals with COPD in a multifaceted way, causing many disabilities. Progressive relaxation exercises (PREs) are an important intervention in reducing symptoms and comorbidity. The aim of this study was to determine the effects of PREs on dyspnea and anxiety levels in individuals with COPD. A pretest-posttest randomized controlled trial was conducted at the chest diseases clinic of a university hospital in Turkey. Forty-four patients with COPD who met the inclusion criteria for participation in the study were assigned either to an intervention or a control group, with 22 patients in each group. In the intervention group, the patients performed PREs once a day for 4 weeks in addition to the standard treatment. The patients in the control group received the standard treatment. In the data collection stage of the study, questionnaire forms, namely, the Modified Borg Scale (MBS), Modified British Medical Research Council Dyspnea Scale, COPD Assessment Test (CAT), and Beck Anxiety Inventory (BAI), were used. Data were collected before (the first follow-up) and after the intervention (the second follow-up). In the second follow-up, the MBS, BAI, and CAT scores decreased significantly in the intervention group ( P < .05) but showed no significant changes in the control group ( P > .05). This study demonstrates that PREs can reduce dyspnea and anxiety levels in individuals with COPD.